GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $822,717 | +203.4% | 18,900 | +203.6% | 0.79% | +253.1% |
| Q1 2022 | $271,161 | -5.0% | 6,225 | -3.9% | 0.22% | -3.0% |
| Q4 2021 | $285,548 | +8.0% | 6,475 | -6.4% | 0.23% | -1.3% |
| Q3 2021 | $264,413 | -11.9% | 6,920 | -8.1% | 0.23% | -35.5% |
| Q2 2021 | $300,000 | +11.5% | 7,530 | 0.0% | 0.36% | +45.2% |
| Q1 2021 | $269,000 | +15.9% | 7,530 | +19.2% | 0.25% | +13.1% |
| Q4 2020 | $232,000 | – | 6,315 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |